Company Filing History:
Years Active: 2025
Title: Innovations by Peter Kreymerman
Introduction
Peter Kreymerman is an accomplished inventor based in Raleigh, NC (US). He has made significant contributions to the field of medical treatments, particularly in the area of tissue fillers. His innovative approach addresses the challenges associated with undesired implanted tissue fillers.
Latest Patents
Kreymerman holds a patent for "Methods and compositions for treating undesired implanted tissue filler." This patent describes a method for treating undesired implanted calcium phosphate tissue filler by administering an effective amount of a pharmaceutically acceptable hyperosmotic composition. The hyperosmotic composition may be a hyperosmotic solution, particularly a hyperosmotic aqueous solution. This composition is administered to an area containing the undesired calcium phosphate tissue filler. The administration of the hyperosmotic composition can reduce, dilute, or redistribute an undesired amount or accumulation of implanted calcium phosphate tissue filler. The methods outlined can ameliorate undesired filler that is implanted in an unintended location, that migrates to an undesired location, or that results in an undesired visual result. Additionally, it addresses issues such as compression of surrounding tissue, pain, infection, and inflammation.
Career Highlights
Kreymerman is currently associated with Merz North America, Inc., where he continues to develop innovative solutions in the medical field. His work focuses on improving patient outcomes through advanced treatment methods.
Collaborations
Kreymerman collaborates with notable colleagues, including Wojciech Danysz and Patrick Plitt. Their combined expertise contributes to the advancement of medical technologies and treatments.
Conclusion
Peter Kreymerman is a notable inventor whose work in treating undesired implanted tissue fillers showcases his commitment to innovation in the medical field. His contributions are paving the way for improved patient care and treatment options.